MAGNIMS (Magnetic Resonance Imaging in MS) is a European network of academics that share a common interest in the study of multiple sclerosis using magnetic resonance imaging techniques.
We are MAGNIMS
Such a group has collaborated since 1990 and has collectively made a major contribution to defining the role of MRI in diagnosis and monitoring treatments in MS.
The MAGNIMS network is independent of any other organization and is run by a Steering Committee whose members are:
VU University Medical Centre – Amsterdam, Netherlands
Vall d’Hebron University Hospital – Barcelona, Catalonia
University Hospital Basel – Basel, Switzerland
Glostrup University Hospital – Copenhagen, Denmark
Medical University Graz – Graz, Austria
UCL Institute of Neurology / Queen Square – London, UK
San Raffaele Scientifica Institute / Vita-Salute San Raffaele University – Milano, Italy
Oxford University – Oxford, UK
Sapienza University – Roma, Italy
University of Siena – Siena, Italy
Steering Committee
A. Rovira (Co-Chair)
Department of Radiology, Magnetic Resonance Unit, Hospital Vall d’Hebron, Barcelona, Spain
C. Enzinger (Co-Chair)
Department of Neurology, Medical University Graz, Graz, Austria
F. Barkhof
Department of Neuroradiology, VU University Medical Centre, Amsterdam, The Netherlands.
O. Ciccarelli
NMR Research Unit, Institute of Neurology, University College London, London, UK
N. De Stefano
Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy
M. Filippi
Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University, Ospedale San Raffaele, Milan, Italy
J. Frederiksen
The MS Clinic, Department of Neurology, University of Copenhagen, Glostrup Hospital, Denmark
L. Kappos
Department of Neurology, University Hospital, Kantonsspital, Basel, Switzerland
J. Palace
Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, UK
M. Rocca
Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University, Ospedale San Raffaele, Milan, Italy
J. Sastre-Garriga
Department of Neurology / Neuroimmunology, Multiple Sclerosis Centre of Catalonia, Hospital Vall d’Hebron, Barcelona, Spain
H. Vrenken
Physics and Medical Technology, and Radiology and Nuclear Medicine, VU University Medical Center Amsterdam, The Netherlands
T. Yousry
NMR Research Unit, Institute of Neurology, University College London, London, UK
C. Gasperini
Department of Neurology, Sapienza University, Roma, Italyu